Efficacy of targeted therapies for metastatic small bowel adenocarcinoma treatment: A retrospective study by AGEO

This publication has 28 references indexed in Scilit:

• Peritoneal Metastases in Gastrointestinal Malignancies: A Review of the Pathophysiology of Metastasis and the Tumour Microenvironment
  Journal of Surgical Oncology, 2025
• FOLFIRINOX or FOLFOX for locally advanced or metastatic small bowel adenocarcinoma: PRODIGE 86 – FFCD-GONO – ENGIC 02 – FOLFIRINOX SBA phase II randomized trial
  Digestive and Liver Disease, 2025
• Survival outcomes in small intestine tumors: The role of duodenum, jejunum, and ileum
  International Journal of Cancer, 2025
• Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
  Annals of Oncology, 2022
• Small bowel adenocarcinoma: Results from a nationwide prospective ARCAD‐NADEGE cohort study of 347 patients
  International Journal of Cancer, 2020
• Addition of Bevacizumab to First-Line Palliative Chemotherapy in Patients with Metastatic Small Bowel Adenocarcinoma: A Population-Based Study
  Targeted Oncology, 2019
• Small bowel adenocarcinoma: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO)
  Digestive and Liver Disease, 2018
• Suggestion of added value by bevacizumab to chemotherapy in patients with unresectable or recurrent small bowel cancer
  Cancer Chemotherapy and Pharmacology, 2017
• Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single‐center, open‐label, phase 2 study
  Cancer, 2016
• Chemotherapy with 5‐fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma
  Cancer, 2008